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The relationship between delayed hypersensitivity and antibody production 
has been intensively investigated.  Included in the attempts to define the rela- 
tionship between the two immune phenomena has been the use of antimetabo- 
lites. A folic acid antagonist, methotrexate, suppresses both antibody formation 
and  delayed  hypersensitivity  (1).  In  contrast,  a  nucleic  acid  antagonist,  6- 
mercaptopurine  (6-MP),  suppresses  antibody  formation  in  rabbits  (2),  but 
has been reported to have no effect on delayed hypersensitivity in guinea pigs 
(3). The following study was initiated to determine whether this difference in 
response to 6-MP adequately differentiates the  two immunologic phenomena 
and  to  consider  the  possibility  that  the  effect of 6-MP  is  species-specific, a 
suggestion made in  a  recent paper which  reported  that  6-MP  treatment did 
not affect either antibody formation or delayed hypersensitivity in the guinea 
pig  (4).  This  paper  describes  experiments  in  which  treatment  with  6-MP 
suppressed the development of delayed hypersensitivity in guinea pigs during 
the period of drug administration. 
Materials and Methods 
Animals.--G,,inea pigs were Hartley strain  albinos of both sexes and weighed between 
400 and 550 gin. These animals were weighed daily. 
Sensltlza/ion.--An~rnals were sensitized by intraperitoneal injection of 0.1 ml of a 10 per 
cent suspension of living BCG in physiologic saline (1.0 ml of packed BCG in 10 ml saline). 
Phipps' strain BCG was harvested in saline after growth on Petragnani's medium. 
6-Mercaptopurlnel.--6-MP solutions were prepared daily by dissolving the  drug in  1 N 
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NaOH  (0.15  gm/ml)  at 37°C.  Injections of this mildly irritating solution (pH of  10)  were 
intraperitoneal (ip) or intramuscular (ira) into the deep muscles of the back. 
Cutaneous  tesl~ing.--Anlmals  were tested intradermally on the flank with 0.005 mg PPD 
(Parke,  Davis  & Company)  in 0.1 ml  (equivalent to  1:100 OT).  Reactions were  observed 
and areas of induration were measured at 4, 8, 24, and 48 hours. Measurements reported are 
the maximum responses, which in all cases were observed at 24 hours. 
Fasting.--The  fasted animals were not fed after stimulation with BCG but given only 
water ad lib. supplemented with vitamin C at a concentration of 250 mg/liter. 
TABLE  I 
Skin Reactions  of Guinea Pigs Tested with PPD for Cutaneous  Hypersensitivity 
Treatment 
6-MP, 50 mg/kg/day 
im,  days 0 to 9 
6-MP, 50 mg/kg/day 
ip,  days 0 to 9 
6-MP, 37.5 mg/kg/day 
im,  days 0 to 9 
6-MP, 25 mg/kg/day 
im,  days 0 to 9 
BCG only 
Normal animals not infected with BCG 
Fraction of animals tested having positive reactions* 
Day I0 after 
B  CG infection 
5/2o 
9/12 
S/12 
8/11 
24/30 
o/13 
Day 19 after 
BCG infection 
12/14 
11/12 
9/10 
7/9 
24/26 
0/7 
* Reactions read 24 hours after intradermal injection of 
Only reactions with a  mean diameter of induration of  10 
positive. 
0.005 mg PPD in 0.1 ml saline. 
mm or  greater are recorded as 
R.ESDtTS 
Effect of 6-MP Treatment on Cutaneous  Hypersensitivity.--Table  I shows the 
effect of 6-MP treatment in major experimental  groups.  It can be seen that 
6-MP in the dosage of 50 mg/kg/day, im, begun on the day of BCG stimulation 
suppressed the development of delayed hypersensitivity during  the period of 
drug administration.  When  treatment was discontinued, however, tuberculin 
hypersensitivity developed within 10 days. Lower doses of 6-MP given intra- 
muscularly  were  less  effective in  suppressing  delayed  hypersensitivity  and 
intraperltoneal injections had no suppressive effect. 
The range of skin reactions in the 6-MP-treated and control guinea pigs is 
given in Table II. Fourteen guinea pigs treated with 6-MP are compared with 10 
control animals.  While more control guinea pigs show delayed hypersensitivity 
than the 6-MP-treated animals on day 10, the two groups are indistinguishable J.  R.  HOYER~ L.  W.  HOYER,  R.  A.  GOOD~ AND  R.  M.  CONDIE 
TABLE II 
Effect of 6-MP on the Devdopment of Ddayed  Hypersensitivity  in Guinea Pigs 
Infected with BCG 
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Diameter of induration of skin reactions at 24 hours after skin test with 0.005  mg PPD 
6-MP, 50mg/kg/day 
im,  days 0 to 9 
Test on day 10" 
~m 
15  X  15 
10  X  12 
10  X  10 
9X  12 
8X  10 
Positive reactions~: ......  4/14 
Test on day 19 
mm 
15  2  15 
12  2  12 
10  2  10 
14  X  14 
15  2  20 
20  X  20 
15  X  20 
15  2  15 
12  X  15 
12  X  15 
10  X  10 
9225 
7X8 
12/14 
Test on day 10 
mm 
17  X  25 
14  X  20 
14  X  15 
12  X  12 
12  X  12 
10  X  12 
10  X  10 
92  12 
8/10 
Untreated 
Test on day 19 
mm 
12  X  30 
12  X  20 
15  X  18 
20  X  20 
15  X  15 
15  X  15 
12  X  15 
9X  15 
14  X  14 
1 
9/10 
* Reactions of less than 7 X  7 mm are given as negative (-), for normal animals regularly 
showed reactions up to this size when tested with PPD. 
Only reactions with a mean diameter of induration of 10 mm or greater are recorded as 
positive. 
TABLE III 
Skin Readions  of Guinea Pigs Tested with PPD for Cutaneous Hypersensitivlty 
Treatment 
Fasted days 0 to 11 after BCG infection  ..................... 
BCG only ............................................... 
Normal animals ......................................... 
Fraction of tested animals 
having positive reactions 
Day 10 after BCG infection* 
Ii/15~ 
9/12 
o/6 
* Reactions read 24 hours after intradermal injection of 0.005 mg PPD in 0.1 ml saline. 
Only reactions with a  mean diameter of induration of 10  mm or greater are recorded as 
positive. 
Six guinea pigs died before they could be skin-tested on the 10th day after fasting was 
started. 5OO 
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in the number and size of reactions 10 days after treatment was discontinued 
(day 19). 
Weight loss accompanies administration of 6-MP and might be considered 
a  sign that 6-MP acts as a non-specific toxic agent through debilitation and 
fasting. Table III shows that fasted guinea pigs develop delayed hypersensi- 
tivity as readily as the control animals.  In these fasted animals the net weight 
loss was much greater than in animals receiving the highest dose of 6-MP (Fig. 
1) but delayed hypersensitivity was not affected. 
Effect of 6-MP on Circulating Leukocfles.--A slight depression of circulating 
leukocytes was noted in BCG-stimulated guinea pigs given 50 mg/kg/day of 
6-MP and the major effect was on the number of neutrophils. For contrast, 
the hematologic data for a group of guinea pigs receiving only BCG stimulation 
are also given in Fig. 2. 
Toxicity of 6-MP.--Of 20 guinea pigs stimulated with BCG and then treated 
for 9 days with 6-MP (50 mg/kg/day, im), 6 died between days 10 and 19. 
During this same period 2 of 12 animals receiving 37.5 mg/kg/day, im, and 2 
of 11 receiving 25 mg/kg/day, im, died. Only 2 of 30 control animals sensitized 
with BCG died in the same period and 2 others were sacrificed for histologic 
studies. Greater toxicity was observed in guinea pigs given 10 daily injections 
of 6-MP  (50 mg/kg/day, im) but not stimulated with BCG.  Five of eight 
guinea pigs so treated died by the 16th day after the first injection. 
DISCUSSION 
Tuberculin hypersensitivity following infection  with BCG in  guinea pigs is 
classical  delayed hypersensitivity: circulating antibody  cannot  be  detected 
and  the hypersensitivity is  readily transferred to  normal  guinea  pigs  with 
leukocytes from sensitized donors (5). Cellular infiltration at skin test sites is 
predominantly mononuclear as contrasted with the polymorphonuclear inva- 
sion present in Arthus hypersensitivity (6). 
In studying the mechanism by which delayed hypersensitivity develops,  a 
wide range of agents which effectively suppress  the sensitization process have 
been investigated.  These include x-irradiation  (7),  hormones  (8),  folic  acid 
antagonists (1, 9), large doses of antigen (10), and antilymphocyte serum (11). 
The  experiments reported  here  indicate  that  another  type  of  chemical,  a 
nucleic acid antimetabolite, also suppresses the development of delayed hyper- 
sensitivity during the period of drug administration. 
Schwartz et al. found that antibody production in the rabbit was inversely 
proportional to 6-MP dosage (2). Subsequently, it has been shown that 6-MP 
prevents  the secondary immune reaction (12), prolongs  homograft survival 
(13), and prevents the development of experimental allergic encephalomyelitis 
(14) during the period of drug administration. 
Although large doses of 6-MP were required to inhibit the development of 684  6-MERCAPTOPURINE AND DELAYED HYPERSENSITIVITY 
tuberculin hypersensitivity, most of the BCG-sensitized guinea pigs tolerated 
the drug quite well. There was minimal  weight  loss, moderate mortality,  and 
relatively mild  leukopenia.  Moreover,  the  same  animals  developed delayed 
hypersensitivity reactions when administration of 6-MP was discontinued. The 
possibility that 6-MP had allowed dissemination of the mycobacteria was con- 
sidered,  for  the  absence  of  delayed  sensitivity  might  have  followed  over- 
whelming  infection.  Histologic studies of the lungs  and livers of guinea pigs 
sacrificed after BCG infection failed to show any consistent difference between 
control and 6-MP-treated animals,  however. 
The present study differs in several ways from previously reported investiga- 
tions  of the  effect of 6-MP  on  delayed hypersensitivity  (3,  4).  Our  results 
indicate that intramuscular injection of 6-MP is much more effective in sup- 
pressing  delayed hypersensitivity that  intraperitoneal  injection  and  that  at 
least 37.5 mg/kg/day must be administered to the guinea pigs. We also used a 
different method of antigenic stimulation and this may account for the different 
findings.  Salvin  studied  the  effect of  6-MP  in  guinea  pigs  given  a  protein 
antigen  in  an  adjuvant  emulsion  (3).  In  contrast,  we  sensitized  guinea 
pigs with living BCG in a saline suspension and in this way avoided the inten- 
sive  stimulation  which  follows  from  adjuvant  administration.  In  antibody 
formation also, the effect of 6-MP is much greater in animals sensitized  without 
adjuvants (15). 
Genghof and Battisto concluded from their experiments that 6-MP affected 
neither delayed hypersensitivity nor antibody formation in the guinea pig and 
ascribed this to a species difference in response to the drug (4). In view of the 
findings  presented here,  a  more likely explanation  is that  they used dosages 
(9 mg/kg/day, im, and 40 mg/kg/day, ip) which were inadequate to obtain an 
anti-immunologic effect in the guinea pig. When adequate doses are adminis- 
tered, 6-MP suppresses both antibody formation (16) and delayed hypersensi- 
tivity in the guinea pig. 
SUMMARY 
The development of tuberculin hypersensitivity in guinea pigs after BCG 
stimulation was suppressed by intramuscular administration of 50 mg/kg/day 
of 6-mercaptopurine started at the time of stimulation. Fasting of guinea pigs 
after BCG stimulation had no effect on the development of tuberculin hyper- 
sensitivity. 
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